European Medicines Agency Recommends Several New Medications for Approval

The European Medicines Agency's Committee for Medicinal Products for Human Use has advised the approval of eight new drugs and 13 expanded indications for existing treatments. Among the key recommendations is Jascayd, intended for the treatment of idiopathic and progressive pulmonary fibrosis. This development could introduce new therapeutic options for patients in the region.